Skip to main content
HWAIL PHARM. CO., LTD logo

HWAIL PHARM. CO., LTD — Investor Relations & Filings

Ticker · 061250 ISIN · KR7061250007 KO Manufacturing
Open in API
Filings indexed 273 across all filing types
Latest filing 2025-08-19 Director's Dealing
Country KR South Korea
Listing KO 061250

About HWAIL PHARM. CO., LTD

http://www.hwail.com/

Hwail Pharm. Co., Ltd. is a pharmaceutical company that specializes in the research, development, manufacturing, and distribution of Active Pharmaceutical Ingredients (APIs). The company also provides a range of finished drug formulations, including generic and patented medications, as well as functional health products. A core focus of the organization is maintaining high standards through continuous R&D investment and rigorous quality control processes to develop and produce its pharmaceutical products.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is specifically used to report changes in share ownership by company insiders (directors/executives). According to the provided definitions, this falls under 'Director's Dealing' (DIRS), which covers personal share transactions and ownership changes by company directors and executives.
2025-08-19 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for Hwail Pharmaceutical Co., Ltd., covering the period from January 1, 2025, to June 30, 2025. It contains detailed corporate information, financial data, management discussions, and governance details typical of a formal interim financial report filed with the Financial Services Commission and the Korea Exchange. It is not an announcement of a report, but the report itself. H1 2025
2025-08-13 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea (DART system) used when an entity's shareholding in a company crosses a significant threshold (typically 5%). The document explicitly mentions '정정신고' (Correction Report) and provides detailed tables regarding changes in share ownership, acquisition methods, and the purpose of holding (management influence). This falls under the category of Major Shareholding Notification.
2025-08-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed in Korea. This type of filing is used to report changes in share ownership by major shareholders or insiders. In the provided taxonomy, 'Major Shareholding Notification' (MRQ) is the correct category for notifications regarding changes in significant share ownership levels, including those by major shareholders.
2025-08-08 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (Osung Advanced Materials Co., Ltd.) in a listed company (Hwail Pharm Co., Ltd.) due to market purchases. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-08-08 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service (Korea). This type of filing is a mandatory disclosure for major shareholders or executives when their shareholding status changes. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers insider transactions and changes in ownership by major stakeholders.
2025-08-01 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.